Bruns Ingmarinsider trades

In SEC Form 4 filings, Bruns Ingmar is listed as Chief Medical Officer of Zentalis Pharmaceuticals, Inc. (ZNTL). Bruns Ingmar reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 1.

Companies and roles

Company	Role	Transactions	Last filed
ZNTLZentalis Pharmaceuticals, Inc.	Chief Medical Officer	1	Oct 1

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-01

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
ZNTLZentalis Pharmaceuticals, Inc.	Sep 30	Oct 1	A	9,727	$2.18	$21,205	43,059	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.